EXAS vs WULF · rev $2.76B vs rev $78.8M
EXACT Sciences Corporation (EXAS) versus Terawulf Inc (WULF) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Terawulf Inc (WULF) is a capital markets company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported WULF revenue for 2026-06-30 was $78.8M. Net income was -$1.37B. WULF currently screens at market cap $2.05B.
EXAS currently screens at market cap $20.03B. WULF currently screens at market cap $2.05B.
Not investment advice. Open the EXAS and WULF stock pages for the full models.
Not investment advice.